Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
EXAS
EXAS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EXAS News
Exact Sciences Reports Q4 Pretax Loss of $85.083 Million
1d ago
moomoo
Exact Sciences Reports Q4 Operating Loss of $82.595 Million
1d ago
moomoo
Exact Sciences Reports Q4 Revenue of $878.381 Million, Exceeding IBES Estimate of $860.9 Million
1d ago
moomoo
Exact Sciences Reports Significant Revenue Growth in Q4
1d ago
NASDAQ.COM
Abbott Laboratories: A Steady Dividend Growth King
3d ago
Fool
Investor Rights Law Firm Investigates Multiple Companies
5d ago
Globenewswire
Monteverde Law Firm Investigates Multiple Mergers
5d ago
Globenewswire
3 Strategies to Calm Stock Market Anxiety Ahead of Key Jobs Report
6d ago
Barron's
Hims & Hers Introduces New Cancer Test, But It Might Not Be Fully Prepared for Use.
Feb 06 2026
Barron's
Exact Sciences' Sale to Abbott Clears HSR Waiting Period
Feb 06 2026
seekingalpha
Investor Rights Law Firm Investigates Multiple Companies for Securities Violations
Feb 03 2026
Globenewswire
Exact Sciences Celebrates Passage of Landmark Cancer Detection Legislation
Feb 03 2026
Businesswire
Passage of MCED Legislation Marks Milestone for Early Cancer Detection
Feb 03 2026
Newsfilter
Oncotype DX Test Surpasses 2 Million Patients Worldwide
Feb 03 2026
Newsfilter
Halper Sadeh LLC Investigates Multiple Companies for Securities Violations
Feb 02 2026
Globenewswire
Abbott Laboratories Reports Disappointing Q4 Results, Shares Decline
Feb 02 2026
Fool
Show More News
